Cancer surveillance following orthotopic liver transplantation

Gastrointestinal Endoscopy Clinics of North America

Volumn 11, Issue 1, 2001, Pages 199-214

  Trotter, J F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ANUS CANCER; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; COLON CANCER; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS CANCER; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; STOMACH CANCER; ULCERATIVE COLITIS; WART VIRUS;

EID: 0035139357     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1052-5157(18)30094-1     Document Type: Review

References (65)

1. Cancer risk after renal transplantation in the Nordic countries
2. Liver transplantation for hepatocellular carcinoma
3. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease
4. Malignant disease in renal transplant patients
5. The incidence of adenocarcinoma in columnar-lined Barrett's esophagus
6. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population-based clinical and autopsy findings
7. The epidemiology of colorectal polyps
8. Hepatocellular carcinoma associated with hepatitis B in a renal graft recipient
9. External anogenital lesions in organ transplant recipients: A clinicopathologic and virologic assessment
10. Colon carcinoma in patients undergoing liver transplantation
11. The risk of ano-genital malignancies in dialysis and transplant patients
12. Gastrointestinal carcinomas in renal transplant recipients
13. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
14. Long-term outcome of hepatitis C infection after liver transplantation
15. World Health Organization criteria for screening
16. Orthotopic liver transplantation for primary sclerosing cholangitis: A 12-year single center experience
17. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension
18. Barrett's esophagus: Development of dysplasia and adenocarcinoma
19. Need for hepatocellular carcinoma screening before renal transplantation in HBS+, HBE+, Western African
20. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis
21. Organospecific activation of azathioprine in mice: Role of liver metabolism in mutation induction
22. Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus
23. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data
24. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
25. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors
26. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome
27. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation
28. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation
29. Risk of neoplasia in renal transplant patients
30. Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infection
31. The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses
32. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
33. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant
34. Liver transplantation for sclerosing cholangitis
35. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients
36. Orthotopic liver transplantation for hepatocellular carcinoma: Factors affecting long-term patient survival
37. Immunosuppression in patients with Barrett's esophagus
38. HPV infection and disease in men
39. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer
40. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders
41. Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases
42. Cancers following cyclosporine therpy
43. Posttransplantation de novo tumors in liver allograff recipients
44. Tumors after renal and cardiac transplantation
45. Colonic disease in cirrhosis: An endoscopic evaluation in 412 patients
46. Second primary cancers following anal and cervical carcinoma: Evidence of shared etiologic factors
47. Solid tumors after liver transplantation
48. The Practice Parameters Committee of the American College of Gastroenterology: Practice Guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus
49. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis
50. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation
51. Squamous cell carcinoma of the esophagus in association with long-term immunosuppressive therapy
52. Role of screening colonoscopy in elective liver transplantation evaluation
53. Development of malignancy following renal transplantation in Australia and New Zealand
54. Management of posttransplantation viral hepatitis C
55. Reduced incidence of rectal cancer, compared to gastric and colonic cancer in a population of 73,076 men and women chronically immunosuppressed
56. Malignancies after liver transplantation: A comparative review
57. Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation
58. Utility of endoscopic evaluations in liver transplant candidates
59. Current concepts in primary sclerosing cholangitis
60. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps
61. Rapid progression of gastroesophageal junction adenocarcinoma after liver transplantation
62. Mutagenicity of cyclosporin: Induction of sister chromatid exchange in human cells
63. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation